Results 91 to 100 of about 14,798 (236)

Challenges in Surveillance for Chikungunya Virus (CHIKV) Infection

open access: yesOnline Journal of Public Health Informatics, 2015
We describe challenges and lessons learned using biosurveillance methods for identifying Chikungunya (CHIKV) infections. Surveillance was performed using VA ESSENCE, electronic laboratory data and facility reports. As of Aug. 14, 2014, 21 confirmed/probable cases were identified at 10 hospitals.
Lucero-Obusan, Cynthia A.   +3 more
openaire   +2 more sources

Clinical, Serological, and Molecular Profile of Dengue Patients With Warning Signs During the 2024 Outbreak in Belo Horizonte, Brazil

open access: yesJournal of Medical Virology, Volume 98, Issue 1, January 2026.
ABSTRACT Dengue poses a significant arboviral threat in Brazil, with 2024 recording the largest outbreak to date. This prospective observational study was conducted during the 2024 outbreak with unvaccinated patients at Eduardo de Menezes Hospital, Belo Horizonte.
Samille Henriques Pereira   +13 more
wiley   +1 more source

A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development

open access: yesViruses, 2022
Chikungunya virus (CHIKV) is a mosquito-borne alphavirus that recently re-emerged in many parts of the world causing large-scale outbreaks. CHIKV infection presents as a febrile illness known as chikungunya fever (CHIKF).
Thaíse Yasmine Vasconcelos de Lima Cavalcanti   +3 more
semanticscholar   +1 more source

Emerging and reemerging arboviruses: a new threat in Eastern Peru [PDF]

open access: yes, 2017
Background: Arboviral diseases are one of the most common causes of acute febrile illness (AFI) and a significant health problem in South America. In Peru, laboratory etiologic identification of these infections occurs in less than 50% of cases, leading ...
Valle Mendoza, Luis Javier del
core   +2 more sources

Strategic Preparedness of Broad‐Spectrum Antivirals for Rapid Response Towards Next Pandemics

open access: yesSmall Science, Volume 6, Issue 1, January 2026.
Nanoengineered broad‐spectrum antivirals (BSAs) represent a transformative approach to pandemic preparedness. Unlike virus‐specific drugs requiring separate development, BSAs act across multiple viral families through nanoengineering strategies that enhance solubility, bioavailability, and host‐targeted activity.
Sanoj Rejinold N   +2 more
wiley   +1 more source

Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus [PDF]

open access: yes, 2013
Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus that causes global epidemics of a debilitating polyarthritis in humans. As there is a pressing need for the development of therapeutic agents, we screened 230 new mouse anti-CHIKV monoclonal ...
A Roussel   +76 more
core   +13 more sources

From eggs to bites: do ovitrap data provide reliable estimates of Aedes albopictus biting females? [PDF]

open access: yes, 2017
Background. Aedes albopictus is an aggressive invasive mosquito species that represents a serious health concern not only in tropical areas, but also in temperate regions due to its role as vector of arboviruses.
Caputo, Beniamino   +3 more
core   +3 more sources

Efficacy of a Combined Natural Extract of Turmeric (Curcuma longa) and Liquorice (Glycyrrhiza uralensis) Against Viral Haemorrhagic Septicaemia Virus in Olive Flounders (Paralichthys olivaceus)

open access: yesJournal of Fish Diseases, Volume 49, Issue 1, January 2026.
ABSTRACT Viral haemorrhagic septicaemia virus (VHSV) causes a high mortality rate in cultured olive flounder, and effective treatment for VHSV infection is urgently required. Turmeric (Curcuma longa ) and liquorice (Glycyrrhiza uralensis) are well‐known medicinal plants with a variety of biological activities. Turmeric and liquorice extract combination
Su‐Mi Shin   +5 more
wiley   +1 more source

γδ T Cells Mediate Protective Immunity Following Vaccination with an Insect-Based Chikungunya Fever Vaccine in Mice

open access: yesPathogens
Eilat (EILV)/chikungunya virus (CHIKV) is a chimeric virus that contains the nonstructural proteins and cis-acting sequences of EILV and the structural proteins of CHIKV. EILV/CHIKV vaccination is known to protect with a single dose against wild-type (WT)
Leslie Rodriguez   +7 more
doaj   +1 more source

Chikungunya virus adapts to tiger mosquito via evolutionary convergence: a sign of things to come? [PDF]

open access: yes, 2008
Since 2004, several million indigenous cases of Chikungunya virus disease occurred in Africa, the Indian Ocean, India, Asia and, recently, Europe. The virus, usually transmitted by Aedes aegypti mosquitoes, has now repeatedly been associated with a new ...
Xavier de Lamballerie   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy